<DOC>
	<DOCNO>NCT00199706</DOCNO>
	<brief_summary>The purpose study determine whether 7.2 % NaCl 6 % hydroxyethyl starch lower intracranial pressure ( ICP ) SAH-patients normal moderately elevated ICP placebo control study , describe haemodynamic effect .</brief_summary>
	<brief_title>HyperHAES Versus Placebo - Effect Intracranial Pressure SAH Patients</brief_title>
	<detailed_description>In acute phase SAH , many patient need intensive care treatment control development fatally increase intracranial pressure . One type treatment use osmotherapy . Traditionally mannitol preferred drug , use hypertonic saline solution gain acceptance . The immediate effect seem equivalent good mannitol , seem less adverse effect , hypovolemia , acute renal failure , hyponatremia , rebound increase ICP . Most clinical study patient life-threatening increase ICP observational , show predictable effect hypertonic saline . We want strengthen finding study apply study model placebo control group patient moderately elevate ICP . We also want document haemodynamic effect , measure cardiac output , intrathorasic blood volume extravascular lung water .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Inclusion criterion : Subarachnoid Hemorrhage , source bleed radiologically surgically secure Age &gt; 18 year Mechanically ventilate Sedated Stable hemodynamics Stable intracranial pressure 10 20 mmHg Exclusion criterion : Serum sodium &gt; 160 mmol/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Intracranial Pressure</keyword>
	<keyword>Intracranial Hypertension</keyword>
	<keyword>Hypertonic Solutions</keyword>
	<keyword>Saline Solutions , Hypertonic</keyword>
</DOC>